Thu, December 29, 2011
[ Thu, Dec 29th 2011 ] - Market Wire
Mortgage Rates Inch Upward
Wed, December 28, 2011
Tue, December 27, 2011
Mon, December 26, 2011
Fri, December 23, 2011
Thu, December 22, 2011
[ Thu, Dec 22nd 2011 ] - Market Wire
Akamai to Acquire Cotendo
Wed, December 21, 2011
Tue, December 20, 2011
[ Tue, Dec 20th 2011 ] - Market Wire
"Plug Me In, Light Me Up"
Mon, December 19, 2011
[ Mon, Dec 19th 2011 ] - Market Wire
GCI Extends 4G to Fairbanks

Simulations Plus to Present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference


//science-technology.news-articles.net/content/2 .. c-semi-annual-new-york-micro-cap-conference.html
Published in Science and Technology on Thursday, December 22nd 2011 at 5:08 GMT by Market Wire   Print publication without navigation


LANCASTER, Calif.--([ ])--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, today announced that Walt Woltosz, chairman and chief executive officer, will present at the Sidoti & Company Semi-Annual New York Micro-Cap Conference at 1:20 p.m. ET on Monday, January 9, 2012 in the Estate 3/Alvin room at the Grand Hyatt New York Hotel. Simulations Plus management will be available during the day for one-on-one meetings. To schedule a meeting, please contact your Sidoti representative.

A copy of the investor presentation that will accompany managementas group presentation will be available at the Simulations Plus corporate website ([ www.simulations-plus.com ]) prior to the presentation.

Sidoti & Company, LLC

Sidoti & Company, LLC Micro-Cap Conference is one of the largest micro-cap focused investor events in the U.S., with over 400 institutional investor attendees at the previous micro-cap conference. For more information or to register for the conference, please visit [ http://microcap.sidoti.com ].

About Simulations Plus, Inc.

Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. Simulations Plus, Inc., is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol aSLP.a For more information, visit our Web site at [ www.simulations-plus.com ].


Publication Contributing Sources